GeneDx Holdings Corp. Cash Flow Reinvestment Rate

Latest as of September 2025: 0.69x

GeneDx Holdings Corp. cash flow reinvestment rate. GeneDx Holdings Corp. (WGS) has a Cash Flow Reinvestment Rate of 0.69x as of September 2025, reinvesting $10.86 Million (capex $6.17 Million plus investments $-4.69 Million) from operating cash flow of $15.77 Million. See GeneDx Holdings Corp. (WGS) financial flexibility to measure the company's free cash flow as a share of total liabilities.

Reinvestment Rate

0.69x
(Capex + Investments) / Operating CF

Total Reinvested

$10.86 Million
Capex + Investments

Operating Cash Flow

$15.77 Million
USD

Capital Expenditures

$6.17 Million
USD

Cash Flow Reinvestment Rate of GeneDx Holdings Corp. (2025–2025)

Cash flow reinvestment rate of GeneDx Holdings Corp. from 2025 to 2025. Historical reinvestment intensity for GeneDx Holdings Corp. across 1 annual periods. Explore GeneDx Holdings Corp. (WGS) cash flow to debt to assess how comfortably operating cash covers total debt obligations.

GeneDx Holdings Corp. Cash Flow Reinvestment Rate by Year (2025–2025)

GeneDx Holdings Corp. cash flow reinvestment rate by year from 2025 to 2025. Year-by-year capital reinvestment analysis for GeneDx Holdings Corp.. For the full cash flow conversion analysis, see GeneDx Holdings Corp. cash flow conversion.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2025 0.86x $28.66 Million $33.28 Million $19.02 Million —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow